WC
CVS icon

Whitnell & Co’s CVS Health CVS Stock Holding History

Whitnell & Co’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$4.33M Buy
58,341
+2,250
+4% +$158K 1.33% 22
2019
Q3 		$3.54M Buy
56,091
+4,546
+9% +$269K 1.18% 28
2019
Q2 		$2.81M Sell
51,545
-2,046
-4% -$110K 1.05% 34
2019
Q1 		$2.89M Buy
53,591
+6,503
+14% +$401K 1.11% 33
2018
Q4 		$3.08M Sell
47,088
-4,683
-9% -$350K 1.37% 25
2018
Q3 		$4.08M Buy
51,771
+1,523
+3% +$109K 1.61% 20
2018
Q2 		$3.23M Buy
50,248
+1,725
+4% +$114K 1.35% 25
2018
Q1 		$3.02M Buy
48,523
+365
+0.8% +$26.2K 1.26% 27
2017
Q4 		$3.49M Sell
48,158
-400
-0.8% -$29.1K 1.46% 26
2017
Q3 		$3.95M Sell
48,558
-150
-0.3% -$11.9K 1.72% 13
2017
Q2 		$3.92M Buy
48,708
+197
+0.4% +$15.6K 1.73% 11
2017
Q1 		$3.81M Buy
48,511
+50
+0.1% +$3.99K 1.71% 13
2016
Q4 		$3.82M Sell
48,461
-5,000
-9% -$405K 1.78% 10
2016
Q3 		$4.76M Buy
53,461
+75
+0.1% +$7.08K 1.62% 8
2016
Q2 		$5.11M Buy
53,386
+550
+1% +$54.8K 1.67% 7
2016
Q1 		$5.48M Buy
52,836
+1,510
+3% +$147K 2.04% 6
2015
Q4 		$5.02M Sell
51,326
-47
-0.1% -$4.6K 1.89% 8
2015
Q3 		$4.96M Buy
51,373
+1,350
+3% +$142K 1.95% 9
2015
Q2 		$5.25M Buy
50,023
+3,018
+6% +$308K 1.9% 8
2015
Q1 		$4.85M Sell
47,005
-2,760
-6% -$279K 1.82% 8
2014
Q4 		$4.79M Sell
49,765
-160
-0.3% -$14.1K 1.8% 7
2014
Q3 		$3.97M Sell
49,925
-1,150
-2% -$90.7K 1.59% 9
2014
Q2 		$3.85M Buy
51,075
+137
+0.3% +$10.4K 1.76% 8
2014
Q1 		$3.81M Sell
50,938
-3,525
-6% -$249K 1.79% 9
2013
Q4 		$3.9M Sell
54,463
-682
-1% -$43.8K 1.79% 9
2013
Q3 		$3.13M Sell
55,145
-2,825
-5% -$168K 1.54% 12
2013
Q2 		$3.31M Buy
+57,970
New +$3.36M 1.65% 11

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Whitnell & Co's CVS Position: Q4 2019 in Review

Whitnell & Co increased its CVS Health (CVS) stake by 4% in Q4 2019, buying an estimated $158K and bringing the position to 58,341 shares worth $4.33M. The position accounts for 1.33% of the portfolio, ranked #22.

Whitnell & Co first reported a position in CVS in Q2 2013 and has held it in 27 quarters since. The position peaked at $5.48M in Q1 2016. 1,843 funds tracked by Wall St. Rank hold CVS as of Q4 2019.

  • Whitnell & Co held 58,341 shares of CVS Health worth $4.33M as of Q4 2019.
  • Whitnell & Co bought 2,250 CVS Health shares in Q4 2019, an estimated $158K.
  • CVS Health made up 1.33% of Whitnell & Co's portfolio in Q4 2019, its #22 holding.
  • Whitnell & Co first reported a position in CVS Health in Q2 2013 and has held it in 27 quarters since.
  • Whitnell & Co's CVS Health position peaked at $5.48M in Q1 2016.
  • 1,843 funds tracked by Wall St. Rank held CVS Health as of Q4 2019.

Based on Whitnell & Co's 13F filing for Q4 2019, filed 11 Feb 2020.